Breast Cancer
Breast cancer is a type of cancer that forms in the cells of the breasts, and it can affect both men and women. Symptoms may include a lump in the breast, changes in breast shape or size, and unusual discharge from the nipple.
Metastatic Breast Cancer: Somatostatin Receptor PET Scan Study
We are studying how somatostatin receptors behave in metastatic breast cancer using DOTATOC-68Ga PET scans. This may help us understand the disease better and improve future imaging techniques.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have metastatic breast cancer?
- Have you received at least one line of systemic treatment for your metastatic breast cancer?
- Do you have identifiable liver or bone metastases?
- Are you currently not participating in another clinical trial?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire Grenoble Alpes
Médecine Nucléaire
La Tronche, France
Sponsor: Centre Hospitalier Universitaire Grenoble Alpes
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.